» Articles » PMID: 20817278

Iron-export Ferroxidase Activity of β-amyloid Precursor Protein is Inhibited by Zinc in Alzheimer's Disease

Abstract

Alzheimer's Disease (AD) is complicated by pro-oxidant intraneuronal Fe(2+) elevation as well as extracellular Zn(2+) accumulation within amyloid plaque. We found that the AD β-amyloid protein precursor (APP) possesses ferroxidase activity mediated by a conserved H-ferritin-like active site, which is inhibited specifically by Zn(2+). Like ceruloplasmin, APP catalytically oxidizes Fe(2+), loads Fe(3+) into transferrin, and has a major interaction with ferroportin in HEK293T cells (that lack ceruloplasmin) and in human cortical tissue. Ablation of APP in HEK293T cells and primary neurons induces marked iron retention, whereas increasing APP695 promotes iron export. Unlike normal mice, APP(-/-) mice are vulnerable to dietary iron exposure, which causes Fe(2+) accumulation and oxidative stress in cortical neurons. Paralleling iron accumulation, APP ferroxidase activity in AD postmortem neocortex is inhibited by endogenous Zn(2+), which we demonstrate can originate from Zn(2+)-laden amyloid aggregates and correlates with Aβ burden. Abnormal exchange of cortical zinc may link amyloid pathology with neuronal iron accumulation in AD.

Citing Articles

Brain tissue metal concentrations and Alzheimer's disease neuropathology in total joint arthroplasty patients versus controls.

Ebner B, Erdahl S, Lundgreen C, Vassilaki M, Kremers W, Knopman D Acta Neuropathol. 2025; 149(1):18.

PMID: 39954128 DOI: 10.1007/s00401-025-02856-9.


Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


The role of the FKBP51-Hsp90 complex in Alzheimer's disease: An emerging new drug target.

Jeanne X, Torok Z, Vigh L, Prodromou C Cell Stress Chaperones. 2024; 29(6):792-804.

PMID: 39615785 PMC: 11664163. DOI: 10.1016/j.cstres.2024.11.006.


Animal models of Alzheimer's disease: Current strategies and new directions.

Wang Q, Zhu B, Lei P Zool Res. 2024; 45(6):1385-1407.

PMID: 39572020 PMC: 11668949. DOI: 10.24272/j.issn.2095-8137.2024.274.


Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review.

Mohammadi S, Ghaderi S, Fatehi F Aging Med (Milton). 2024; 7(5):649-667.

PMID: 39507230 PMC: 11535174. DOI: 10.1002/agm2.12363.


References
1.
Klomp L, Farhangrazi Z, Dugan L, Gitlin J . Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest. 1996; 98(1):207-15. PMC: 507418. DOI: 10.1172/JCI118768. View

2.
Bodovitz S, Falduto M, Frail D, Klein W . Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem. 1995; 64(1):307-15. DOI: 10.1046/j.1471-4159.1995.64010307.x. View

3.
Klausner R, Rouault T, Harford J . Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 1993; 72(1):19-28. DOI: 10.1016/0092-8674(93)90046-s. View

4.
Hao Q, Maret W . Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J Alzheimers Dis. 2005; 8(2):161-70. DOI: 10.3233/jad-2005-8209. View

5.
HALLGREN B, SOURANDER P . The effect of age on the non-haemin iron in the human brain. J Neurochem. 1958; 3(1):41-51. DOI: 10.1111/j.1471-4159.1958.tb12607.x. View